Pancreas screening study for people at high cancer risk
Part of Brain & nervous system, Cancer, Digestive system, Genetic & congenital, Hormones & metabolism, Skin clinical trials.
This Phase 3 study tests a structured plan for checking the pancreas early in people with a higher-than-usual risk of pancreatic cancer. The goal is to find changes sooner, when treatment may be easier.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have one of these higher-risk situations: hereditary pancreatitis, Peutz-Jeghers syndrome, or a strong family history of pancreatic cancer.
- Or you carry a known inherited gene change (for example BRCA1/2, PALB2, ATM, CDKN2A/p16, PRSS1/2, SPINK1, CFTR, or Lynch-related genes).
- An endoscopy plan is already scheduled to examine your pancreas.
- A doctor must be able to safely pass the ultrasound scope through your upper stomach area (no blocking strictures).
- You must be able to give informed consent, and you should not be in poor overall health for procedures.
- You must not be pregnant, and you should not have medical bleeding problems that would make endoscopy unsafe.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses MRI scans to screen for pancreas cancer in people at high risk due to family history or certain gene mutations. It aims to see if MRI can help find cancer early.
This study is a registry (a way to track health over time) for people with a strong family history or certain inherited genetic risks for pancreatic cancer. It may help doctors learn how best to monitor and protect high-risk people, and to see who benefits most from follow-up.
This study builds a registry of people with a higher-than-average risk of pancreatic cancer, based on family history or inherited gene conditions. If you join the extra imaging follow-up, it helps your care team monitor risk earlier.
This study builds a database of people at higher risk for pancreatic cancer (or certain early warning findings) to help find better ways to detect the disease early. You may be asked to complete health questionnaires and possibly donate a blood/saliva/swab sample.
This trial uses MRI and endoscopic ultrasound to look for early signs of pancreatic cancer in people who have a high risk due to their genes or family history. Finding it early may lead to better treatment options.
This study offers pancreatic cancer screening for people with strong family history or certain inherited gene changes. It may help find pancreatic cancer earlier, when treatment may be more effective.
Hear when a new Pancreas Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.